STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
90 hedge funds and large institutions have $337M invested in Stemline Therapeutics, Inc. in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 26 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
90
Holders Change
-1
Holders Change %
-1.1%
% of All Funds
2.06%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
8
Increased
34
Reduced
26
Closed
9
Calls
$254K
Puts
$4.08M
Net Calls
-$3.82M
Net Calls Change
-$716K
Top Buyers
| 1 |
PC
1
Pier Capital
Stamford,
Connecticut
|
$4.18M |
| 2 |
PC
2
Polar Capital
London,
United Kingdom
|
$34.1M |
| 3 |
3
BlackRock
New York
|
$32.7M |
| 4 |
4
Invesco
Atlanta,
Georgia
|
$2.27M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$15M |
Top Sellers
| 1 |
1
Adage Capital Partners
Boston,
Massachusetts
|
$11.8M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$25.8M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$14.9M |
| 4 |
4
Two Sigma Investments
New York
|
$1.93M |
| 5 |
5
D.E. Shaw & Co
New York
|
$1.72M |
